Increased expression of the p-STAT3/IL-17 signaling pathway in patients with dermatomyositis
Modern Rheumatology · 22.12.2023 · 34 (1) · 129-136
DOI: 10.1093/mr/roac147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 08.12.2022. Verfasst von Dongmei Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The First Hospital of Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Dermatomyositis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Objectives
The aim is to explore the roles of phosphorylated signal transduction and activator of transcription 3 (p-STAT3) and interleukin (IL)-17 in patients with dermatomyositis (DM).
Methods
A total of 20 DM patients and 12 healthy controls were enrolled. Flow cytometry combined with counting was used to detect the number of Th17 cells. Western blotting and immunohistochemistry were used to examine the muscle levels of p-STAT3 and IL-17, and serum levels of IL-17 were measured by enzyme-linked immunosorbent assays.
Results
Muscle p-STAT3 and IL-17 levels, the number of Th17 cells, and serum IL-17 levels were markedly increased in DM. p-STAT3 and IL-17 were co-expressed in the muscle of DM patients. The p-STAT3 levels were correlated with the number of Th17 cells as well as muscle and serum IL-17 levels. The correlations of the p-STAT3 level with elevated levels of transaminases, myocardial enzymes, and the health assessment questionnaire score were significantly positive, while the correlation with manual muscle testing-8 was significantly negative. A receiver operating characteristic curve indicated the good predictive value of p-STAT3 for the occurrence of DM.
Conclusions
The increased p-STAT3/IL-17 signaling pathway activation in DM patients may induce muscle inflammation and necrosis, and it may be a potential target for DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, The First Hospital of Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Zili Fu
Zitieren
APA
Li, D., Jia, W., Zhou, L., Hao, Y., Wang, K., Yang, B., Yang, J., Luo, D., & Fu, Z. (2023). Increased expression of the p-STAT3/IL-17 signaling pathway in patients with dermatomyositis. Modern Rheumatology, 34(1), 129-136. https://doi.org/10.1093/mr/roac147
Vancouver
Li D, Jia W, Zhou L, Hao Y, Wang K, Yang B, et al. Increased expression of the p-STAT3/IL-17 signaling pathway in patients with dermatomyositis. Modern Rheumatology. 2023;34(1):129-136. doi:10.1093/mr/roac147
BibTeX
@article{Li2023,
author = {Li, Dongmei and Jia, Wen and Zhou, Luyao and Hao, Yiqun and Wang, Kai and Yang, Bo and Yang, Jie and Luo, Dongping and Fu, Zili},
title = {Increased expression of the p-STAT3/IL-17 signaling pathway in patients with dermatomyositis},
journal = {Modern Rheumatology},
year = {2023},
volume = {34},
number = {1},
pages = {129--136},
doi = {10.1093/mr/roac147}
}
EUVIMED